Led by Mark Bergman — 20+ years of hands-on medtech commercialization across the US and Canada. From market strategy to revenue, powered by deep networks and AI-enabled intelligence.
Every engagement is tailored to the regulatory, clinical, and commercial realities of North American medtech — from first-in-market strategy to scaled operations.
In-depth market analysis, competitive landscape assessment, and opportunity mapping for new launches and portfolio expansion.
Learn more →End-to-end go-to-market planning — pricing architecture, channel design, distribution, and launch programs built for adoption.
Learn more →Dual-market launch strategy and market access — with regulatory specialists engaged through Apex's expert network.
Learn more →AI-enabled device strategy, SaMD navigation, and integration of intelligent tools into clinical and commercial workflows.
Learn more →Strategic identification and cultivation of Key Opinion Leaders across key specialties, built on two decades of relationships.
Learn more →Partner identification, due diligence, and advisory for strategics, PE/VC firms, and family offices in medtech.
Learn more →Apex Medical pairs operator experience with a modern digital toolkit — live market intelligence, AI-assisted regulatory research, and Ask Apex, our medtech AI assistant trained on North American commercialization.
A curated bench of senior specialists across every critical function — full-service capability without big-firm overhead.
FDA and Health Canada submissions, quality systems, and regulatory pathway strategy for devices and diagnostics.
HEOR strategy, payer analysis, reimbursement pathways, and value dossiers for North American market access.
AI-enabled tools in clinical and commercial workflows, digital health strategy, and technology assessment.
Device marketing, KOL engagement content, and positioning tailored to HCP and patient audiences.
Team recruitment, structure, compensation, onboarding, and CRM implementation for device organizations.
Commercial tech stack assessment, analytics, and infrastructure advisory for scalable operations.
Live medtech and health technology headlines — updated automatically from leading industry sources.
Deep understanding of your product, goals, and the market dynamics you face in Canada and the US.
A tailored commercialization roadmap — regulatory, pricing, distribution, and clinical engagement.
Hands-on implementation alongside your team — KOL programs, stakeholder relationships, market entry.
Post-launch expansion, performance monitoring, and ongoing strategy optimization.
Mark brought tremendous value as VP of Sales & Marketing — building structured sales processes, refining our market positioning, and elevating our external communications while leading the team day to day. He knows how to translate complex clinical technology into clear, compelling value propositions, and his ability to align marketing strategy with revenue objectives helped our company grow exponentially.
Tell us about your product and objectives. Mark personally reviews every inquiry.
Toronto, Canada — serving clients across North America
Need a quick answer first? Use the chat in the corner — it's trained on medtech commercialization.